[Edaily Reporter Kwon Oh Seok ] NH INVESTMENT & SECURITIES(005940)announced on the 3rd that it held a “Rice of Love” donation ceremony at Ansan City Hall to support vulnerable members of the local community. NH INVESTMENT & SECURITIES President Bae Gwang-soo (left) and Ansan Mayor Lee Min-geun pose for a commemorative photo after the ceremony. (Photo courtesy of NH INVESTMENT & SECURITIES) This donation was made possible after the NH INVESTMENT & SECURITIES Ansan WM Center decided to donate the entire prize money it received for winning the “Chonghwa Award,” the highest honor bestowed by the National Agricultural Cooperative Federation (NACF). The Chonghwa Award is presented by the NACF to the top-performing office after comprehensively evaluating business performance, employee harmony, and social contribution across all affiliated companies. NH INVESTMENT & SECURITIES’ headquarters also joined the Ansan WM Center’s charitable effort by providing an additional donation equal to the prize money through a matching grant program. The rice, worth a total of 10 million won, secured through this initiative, is scheduled to be distributed to vulnerable households in Ansan City. Bae Kwang-soo, President of NH INVESTMENT & SECURITIES, emphasized, “I am grateful to the employees of the Ansan WM Center for coming together to donate the entire award amount,” adding, “I hope this act of generosity will be of some help to our neighbors in the community, and we will continue to fulfill our corporate social responsibility through ongoing social contribution activities.”
Lotte Auto Lease is entering the public corporate bond market backed by a principal and interest payment guarantee from its parent company, LOTTE rental. The company plans to raise a total of 30 billi…
SamsungElectroMechanics is projected to post its best-ever earnings this year, with operating profit approaching 2 trillion won. As demand for components used in artificial intelligence (AI) servers s…
AprilBio Co.,Ltd. CI. (Photo courtesy of AprilBio Co.,Ltd.)
AprilBio Co.,Ltd.(397030)has obtained early preclinical data for its dual-target RNA interference (RNAi) candidate. With a single adminis…